Clinical specificities of patients with substance use disorder and comorbid borderline personality disorder compared to patients with substance use disorder only: a retrospective study

被引:1
|
作者
Blay, Martin [1 ,2 ]
Verne, Manon [3 ]
Durpoix, Amaury [4 ]
Benmakhlouf, Ines [1 ]
Labaume, Laura [1 ]
机构
[1] Outpatient Addictol & Psychiat Ctr, ADDIPSY, 164 Ave Jean Jaures, F-69007 Lyon, France
[2] Univ Paris Saclay, Ctr Rech Epidemiol & Sante Populat Team DevPsy, UVSQ, INSERM, Villejuif, France
[3] Claude Bernard Univ Lyon 1, Lyon Est Med Sch, Lyon, France
[4] Univ Hosp Strasbourg, Dept Psychiat, Strasbourg, France
关键词
Substance use disorder; borderline personality disorder; comorbidity; diagnostic; IMPULSIVITY; ALEXITHYMIA; IMPAIRMENT;
D O I
10.1080/10550887.2024.2363038
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
IntroductionSubstance use disorder (SUD) is a common condition often associated with borderline personality disorder (BPD), and patients with both disorders (SUD + BPD) have more complex presentations and poorer outcomes in treatment. Thus, there is a need to identify more clearly the clinical differences between patients with SUD + BPD and those with SUD only to help clinicians in their diagnostic process.MethodsData from medical files of 92 patients with SUD (SUD only: n = 42; SUD + BPD: n = 50) treated in an outpatient psychiatry and addiction treatment center were extracted to compare the differences in terms of sociodemographic characteristics, substance used, psychopathological dimensions, comorbidity prevalence, and functional impairment.ResultsCompared to the SUD only group, patients in the SUD + BPD group were younger, more disabled, and less satisfied with their social life. Regarding substance used, the comorbid group had more frequently cannabis use disorder and poly nonalcoholic SUD. Regarding psychopathological dimensions, the comorbid group had higher levels of impulsivity, emotion regulation difficulties and alexithymia. Finally, regarding comorbidities, the comorbid group had a higher risk of comorbid anxiety, obsessive-compulsive, and post-traumatic stress disorders.ConclusionWhile being only exploratory, these results add evidence on the impact of the BPD comorbidity in patients with SUD and underline important dimensions that should be considered by clinicians working with this population.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Sexually transmitted disease rates and high-risk sexual behaviors in borderline personality disorder versus borderline personality disorder with substance use disorder
    Chen, Eunice Y.
    Brown, Milton Z.
    Lo, Tracy T. Y.
    Linehan, Marsha M.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2007, 195 (02) : 125 - 129
  • [32] Does the Augmentation of Trauma Informed Hatha Yoga Increase the Effect of Dialectical Behavior Therapy for Substance Use Disorders on Psychopathological Strain of Patients with Borderline Personality Disorder and Comorbid Substance Use Disorder? Results of a Quasi-Experimental Study
    Riegler, Alisa
    Bumb, Jan Malte
    Wisch, Christian
    Schuster, Rilana
    Reinhard, Iris
    Hoffmann, Sabine
    Frischknecht, Ulrich
    Enning, Frank
    Schmahl, Christian
    Kiefer, Falk
    Koopmann, Anne
    EUROPEAN ADDICTION RESEARCH, 2023, 29 (01) : 1 - 8
  • [33] Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder
    Pourmand, D
    Kavanagh, DJ
    Vaughan, K
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (06) : 473 - 478
  • [34] The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study
    Brynte, Christoffer
    Aeschlimann, Myriam
    Barta, Csaba
    Begeman, Alex Hendikus Abraham
    Backer, Amanda
    Crunelle, Cleo Lina
    Daigre, Constanza
    De Fuentes-Merillas, Laura
    Demetrovics, Zsolt
    Dom, Geert
    Grau Lopez, Lara
    Icick, Romain
    Johnson, Brian
    Joostens, Peter
    Kapitany-Foveny, Mate
    Karsinti, Emily
    Kiefer, Falk
    Konstenius, Maija
    Levin, Frances R.
    Luderer, Mathias
    Markus, Wiebren
    Matthys, Frieda
    Moggi, Franz
    Felipe Palma-Alvarez, Raul
    Paraskevopoulou, Maria
    Antoni Ramos-Quiroga, J.
    Schellekens, Arnt
    Soravia, Leila M.
    Therribout, Norman
    Thomas, Anil
    van de Glind, Geurt
    van Kernebeek, Michiel Willem
    Vollstaedt-Klein, Sabine
    Vorspan, Florence
    van den Brink, Wim
    Franck, Johan
    BMC PSYCHIATRY, 2022, 22 (01)
  • [35] Comparison of cognitive functions in bipolar disorder patients with and without comorbid borderline personality disorder
    Baltacioglu, Mehmet
    Kosger, Ferdi
    Essizoglu, Altan
    Gulec, Gulcan
    Akarsu, Ferdane Ozlem
    Yenilmez, Cinar
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 27 (01) : 35 - 40
  • [36] Treatment of patients with comorbidity of substance use disorder and psychotic disorder
    Segrec, Nusa
    Kastelic, Andrej
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (7-8): : 566 - 574
  • [37] Comorbid Attention-Deficit/Hyperactivity Disorder and Mood Disorder in a South African Sample of Substance Use Disorder Patients
    Truter, Ilse
    Regnart, Judith
    Meyer, Anneke
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [38] Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder
    Hashemzadeh, Iman
    Marquez-Arrico, Julia E.
    Hashemzadeh, Kosar
    Navarro, Jose Francisco
    Adan, Ana
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [39] Gender Differences in Cognitive and Personality Functioning in Patients With Substance Use Disorder
    Hoijer, Irma
    Ilonen, Tuula
    Loyttyniemi, Eliisa
    Salokangas, Raimo K. R.
    ADDICTIVE DISORDERS & THEIR TREATMENT, 2021, 20 (04) : 538 - 547
  • [40] Personality traits as predictors of recovery among patients with substance use disorder
    Fodstad, Elise Constance
    Erga, Aleksander Hagen
    Ushakova, Anastasia
    Erevik, Eilin Kristine
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 162